CollPlant Biotechnologies Ltd. Share Price
Equities
CLGN
IL0004960188
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 USD | +9.89% | +13.27% | -7.82% |
Sales 2024 * | 10.53M 2.77M 231M | Sales 2025 * | 53.98M 14.18M 1.18B | Capitalization | 257M 67.58M 5.63B |
---|---|---|---|---|---|
Net income 2024 * | -60M -15.76M -1.31B | Net income 2025 * | -24M -6.3M -526M | EV / Sales 2024 * | 24.4 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.77 x |
P/E ratio 2024 * |
-4.15
x | P/E ratio 2025 * |
-10.3
x | Employees | 75 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.27% |
1 day | +9.89% | ||
1 week | +13.27% | ||
Current month | +10.09% | ||
1 month | +12.40% | ||
3 months | +17.80% | ||
6 months | +10.71% | ||
Current year | -7.82% |
Managers | Title | Age | Since |
---|---|---|---|
Yehiel Tal
CEO | Chief Executive Officer | 71 | 01/10/01 |
Oded Shoseyov
FOU | Founder | 67 | 01/04/01 |
Eran Rotem
DFI | Director of Finance/CFO | 56 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Avri Havron
BRD | Director/Board Member | 75 | 01/16/01 |
Hugh Evans
BRD | Director/Board Member | 57 | 29/21/29 |
Elan Penn
BRD | Director/Board Member | 72 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.89 | +9.89% | 5,873 |
25/24/25 | 5.36 | -0.92% | 5,882 |
24/24/24 | 5.41 | +0.19% | 1,040 |
23/24/23 | 5.4 | +2.66% | 12,622 |
22/24/22 | 5.26 | +1.15% | 4,270 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.82% | 67.46M | |
-28.51% | 925M | |
-20.60% | 128M | |
+6.64% | 60.58M | |
+14.87% | 61.68M | |
+0.60% | 51.45M |
- Stock Market
- Equities
- CLGN Stock